Discussing Key Updates in the Management of Patients with Demodex Blepharitis

Elizabeth Yeu, MD, provides a comprehensive overview of Demodex blepharitis stemming from infestations of eyelash follicle mites.

Elizabeth Yeu, MD, discusses complications that may arise from inadequate treatment of Demodex blepharitis.

Key questions to ask patients during diagnosis of Demodex blepharitis to identify signs and symptoms of the condition are covered by Dr. Yeu.

Factors that differentiate Demodex blepharitis apart from other lid margin and ocular surface diseases with overlapping signs and symptoms are examined.

Dr. Yeu examines risk factors for Demodex blepharitis, including patients with diabetes and immunosuppression.

An overview of the current landscape of available treatment options for Demodex blepharitis is analyzed.

Neda Shamie, MD, summarizes the prevalence and clinical manifestations of Demodex Blepharitis.

An expert ophthalmologist discusses a medication which targets enzymes in the Demodex mite, given over a six-week course. 

A review of insurance policies for Demodex blepharitis treatments, along with an analysis of the potential toxicities associated with these treatments.

Dr Shamie shares her optimism in the advancement of Demodex Blepharitis treatment.

Eric D. Donnenfeld, MD; discusses the importance of understanding the pathogenesis of Demodex blepharitis to reach a proper diagnosis.

An expert provides insights into the cost of misdiagnosed Demodex blepharitis and payer considerations for a potential cost-effective treatment.

Eric D. Donnenfeld, MD; underscores the significance of an FDA approved treatment for Demodex blepharitis as well as past alternative treatments.